Conference Coverage

Positive headway reported for progressive multiple sclerosis

Publish date: February 25, 2016

 

EXPERT ANALYSIS FROM ACTRIMS FORUM 2016

References

Dr. Lublin reported receiving research support and/or serving as a consultant for many companies marketing MS drugs, including Biogen, Genentech, and Novartis.

Pages

Recommended Reading

Does Fatigue Worsen Spasticity in Patients With MS?
MDedge Neurology
VIDEO: Bench research provides insight into progressive MS
MDedge Neurology
Peter Chin, MD
MDedge Neurology
Brian Sandroff, PhD
MDedge Neurology
VIDEO: Progressive MS trial failures provide lessons for future success
MDedge Neurology
Potential biomarkers of gray matter damage in MS identified
MDedge Neurology
Treatment justified even for moderately advanced MS disability
MDedge Neurology
Blood-borne biomarkers of MS relapse identified
MDedge Neurology
Ocrelizumab subanalysis hints at better efficacy with active inflammatory lesions
MDedge Neurology
VIDEO: MS stem cell therapy research progresses, including oligodendrocyte progenitor trial
MDedge Neurology

Related Articles